Cited by 40Pluripotent Stem Cells ResearchAlzheimer's disease research and treatmentsCRISPR and Genetic Engineering

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line

Open access
Schmid, Benjamin, Prehn, Kennie R., Nimsanor, Natakarn, Garcia, Blanca Irene Aldana, Poulsen, Ulla, Jørring, Ida, Rasmussen, Mikkel A., Clausen, Christian +9 more·2019·Stem Cell Research

Abstract

Alzheimer's disease (AD) is the most frequent neurodegenerative disease amongst the elderly. The SNPs rs429358 and rs7412 in the APOE gene are the most common risk factor for sporadic AD, and there are three different alleles commonly referred to as APOE-ε2, APOE-ε3 and APOE-ε4. Induced pluripotent stem cells (iPSCs) hold great promise to model AD as such cells can be differentiated in vitro to the required cell type. Here we report the use of CRISPR/Cas9 technology employed on iPSCs from a healthy individual with an APOE-ε3/ε4 genotype to obtain isogenic APOE-ε2/ε2, APOE-ε3/ε3, APOE-ε4/ε4 lines as well as an APOE-knock-out line.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.scr.2018.11.010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Isogenic APOE iPSCs obtained from EBiSC show mono-allelic expression of APOE, or APOE deletion.

    “Isogenic APOE iPSCs were obtained from the European Bank for Induced Pluripotent Stem Cells (EBiSC), and show mono-allelic expression of APOE, or APOE deletion (Schmid et al., 2019, 2020).”

    From APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes (2022) · cites this paper as Schmid et al., 2019

    The Resource table identifies the isogenic APOE iPSC lines as EBiSC resources, and Resource details describes homozygous APOE-ε2/ε2, ε3/ε3 and ε4/ε4 lines plus an APOE knock-out line. The characterization passage confirms the knock-out lacks ApoE protein. None of these passages establishes mono-allelic APOE expression; a homozygous genotype does not by itself demonstrate expression from only one allele. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • The iPSC lines used harbor a single APOE2, APOE3, or APOE4 allele generated using CRISPR, or an APOE-KO generated by an insertion-deletion mutation in exon 2.

    “iPSC lines were purchased from EBiSC (BIONi010-C-2, -C-3, C-4, and -C-6), harboring a single APOE2, APOE3, or APOE4 allele generated using CRISPR, or an APOE-KO generated by an insertion-deletion mutation in exon 2 (Schmid et al., 2019, 2020).”

    From APOE2, E3, and E4 differentially modulate cellular homeostasis, cholesterol metabolism, and inflammatory response in isogenic iPSC-derived astrocytes (2022) · cites this paper as Schmid et al., 2019

    The Resource table identifies the four EBiSC lines, and Resource details reports CRISPR-generated APOE-ε2/ε2, ε3/ε3 and ε4/ε4 lines plus an APOE knockout with a frameshift in exon 2. The variant lines are homozygous, not single-copy APOE allele lines. The paper describes deleting part of exon 2 but does not specify an insertion-deletion mutation. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Schmid, B., Prehn, K. R., Nimsanor, N., Garcia, B. I. A., Poulsen, U., Jørring, I., Rasmussen, M. A., Clausen, C., Mau-Holzmann, U. A., Ramakrishna, S., Muddashetty, R., Steeg, R., Bruce, K., Mackintosh, P., Ebneth, A., Holst, B., & Cabrera-Socorro, A.
Affiliations
  • Bioneer (Denmark) (DK)
  • Mahidol University (TH)
  • University of Tübingen (DE)
  • University of Trans-Disciplinary Health Sciences and Technology (IN)
  • Institute for Stem Cell Biology and Regenerative Medicine (IN)
  • Janssen (Belgium) (BE)
Corresponding author
Schmid, Benjamin
Venue
Stem Cell Research
Publisher
Elsevier BV
Published
2019-01
Volume
34
Pages
101349
ISSN
1873-5061 (ISSN-L)
OpenAlex
W2908300127
Cited by
40
References
1
Citations by year
2026: 1 · 2025: 7 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 10 · 2020: 5 · 2019: 1
FWCI
1.64
Type
journal article
Language
en
Update notices
erratum (2020-10-01)
Open access
Locations
  • Stem Cell Research (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc-nd)
  • Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, cc-by)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Danish Agency for Science, Technology and Innovation (6114-00003B-768138)
  • European Union's Seventh Framework programme FP7 under REA (PIAPP-GA-2012-324451)
  • BrainStem – Stem cell Centre of Excellence in Neurology (4108-00008B)
  • Innovative Medicines Initiative (115582)
  • European Union's Seventh Framework Programme (FP7/2007-2013)
  • EFPIA
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
Alzheimer's disease, apolipoprotein E, induced pluripotent stem cells, CRISPR/Cas9 genome editing, isogenic cell lines, APOE ε4, APOE ε2, APOE ε3, apolipoprotein E deficiency, rs429358, rs7412, disease modeling
MeSH terms
Gene Editing, Adolescent, Apolipoproteins E, Cell Line, Homozygote, Humans, Male, Mutation, Cell Culture Techniques, Gene Knockout Techniques, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review